Skip to main content

Table 1 Clinical characteristics of the study cohort (n = 93)

From: Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma

 

LUAD (n = 80)

Healthy individuals (n = 13)

Age (years), median (range)

60.31 (32–77)

48(29–66)

 < 60, n (%)

41 (51.25)

7 (53.85)

 ≥ 60, n (%)

39 (48.75)

6 (46.15)

Gender, n (%)

 Male

22 (27.50)

5 (38.46)

 Female

58 (72.50)

8 (61.54)

Stage

 TIA1, n (%)

15 (18.75)

–

 TIA2, n (%)

38 (47.50)

–

 TIA3, n (%)

27 (33.75)

–

Infiltration

 MIA, n (%)

17 (21.25)

–

 IA, n (%)

63 (78.75)

–